Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis

Arthritis and Rheumatism

Volumn 39, Issue 12, 1996, Pages 2004-2012

  Clegg, Daniel O ^a,m   Reda, Domenic J ^b   Weisman, Michael H ^a   Blackburn, Warren D ^c   Cush, John J ^d   Cannon, Grant W ^a   Mahowald, Maren L ^a   Schumacher Jr , H Ralph ^a   Taylor, Thomas ^e   Budiman Mak, Elly ^a   Cohen, Miriam R ^f   Vasey, Frank B ^a   Luggen, Michael E ^a   Mejias, Edwin ^g   Silverman, Stuart L ^a   Makkena, Rama ^h   Alepa, F Paul ⁱ   Buxbaum, Joel ^a   Haakenson, Clair M ^j   Ward, Richard H ^k   Manaster, B J ^k   Anderson, Robert J ^b,l   Ward, John R ^k   Henderson, William G ^b   more..

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Hines VA Cooperative Studies Program (CSP) Coordinating Center   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

^d VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^e VA MEDICAL CENTER   (United States)

^f CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g VAMC   (Puerto Rico)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^j University of New Mexico   (United States)

^k UNIVERSITY OF UTAH   (United States)

^l UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^m UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SALAZOSULFAPYRIDINE;

ADULT; ALOPECIA; ANKYLOSING SPONDYLITIS; ARTICLE; BACKACHE; CHILL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RIGIDITY; SACROILIITIS; SKIN TOXICITY; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PATIENT COMPLIANCE; PLACEBOS; SPONDYLITIS, ANKYLOSING; SULFASALAZINE; TREATMENT REFUSAL;

EID: 0012910310     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780391209     Document Type: Review

References (21)

1. Amor B, Kahn A, Dougados M, Delrieu F: Sulfasalazine and ankylosing spondylitis (letter). Ann Intern Med 101:878, 1984
2. Dougados M, Boumier P, Amor B: Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. BMJ 293:911-914, 1986
3. Feltelius N, Hallgren R: Sulphasalazine in ankylosing spondylitis. Ann Rheum Dis 45:396-399, 1986
4. Nissilä M, Lehtinen K, Leirisalo-Repo M, Luukkainen R, Mutru O, Yli-Kerttula U: Sulfasalazine in the treatment of ankylosing spondylitis: a twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum 31:1111-1116, 1988
5. Davis MJ, Dawes PT, Beswick E, Lewin IV, Stanworth DR: Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity immunoglubulin A, and the complex immunoglobulin A antitrypsin. Br J Rheumatol 28:410-413, 1989
6. Corkill MM, Jobanputra P, Gibson T, MacFarlane DG: A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect. Br J Rheumatol 29:41-45, 1990
7. Fraser SM, Sturrock RD: Evaluations of sulphasalazine in ankylosing spondylitis - an interventional study. Br J Rheumatol 29: 37-39, 1990
8. Taylor HG, Beswick EJ, Dawes PT: Sulphasalazine in ankylosing spondylitis: a radiological, clinical and laboratory assessment. Clin Rheumatol 10:43-48, 1991
9. Dougados M, van der Linden S, Leirisalo-Repo M, Huitfeldt B, Juhlin R, Veys E, Zeidler H, Kvien TK, Olivieri I, Dijkmans B, Bertouch J, Brooks P, Edmonds J, Major G, Amor B, Calin A: Sulfasalazine in the treatment of spondylarthropathy: a randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 38:618-627, 1985
10. Van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 27:361-368, 1984
11. Williams HJ, Ward JR, Reading JC, Egger MJ, Grandone JT, Samuelson CO, Furst DE, Sullivan JM, Watson MA, Guttadauria M, Cathcart ES, Kaplan SB, Halla JT, Weinstein A, Plotz PH: Low-dose D-penicillamine therapy in rheumatoid arthritis: a controlled, double-blind clinical trial. Arthritis Rheum 26:581-592, 1983
12. Dougados M, Gueguin A, Nakache J, Nguyen M, Mery C, Amor B: Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 15:302-307, 1988
13. Mander M, Simpson JM, McLellan A, Walker D, Goodacre JA, Dick WC: Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 46:197-202, 1987
14. Moll JMH, Wright V: An objective clinical study of chest expansion. Ann Rheum Dis 31:1-8, 1972
15. Rodnan GP, Schumacher HR, editors: Primer on the Rheumatic Diseases. Eighth edition. Atlanta, Arthritis Foundation, 1983
16. SAS Institute, Inc.: SAS/STAT User's Guide: Version 6. Fourth edition. Cary, NC, SAS Institute, Inc., 1990
17. Diggle P, Liang K, Zeger S: Analysis of Longitudinal Data. Oxford, Clarendon Press, 1994
18. SAS Institute Inc.: SAS Technical Report P-229, SAS/STAT: Changes and Enhancements, Release 6.07. Cary, NC, SAS Institute Inc., 1992
19. Hedeker D, Gibbons RD: A random-effects ordinal regression model for multilevel analysis. Biometrics 50:933-944, 1994
20. Ferraz MB, Tugwell P, Goldsmith CH, Astra E: Meta-analysis of sulfasalazine in ankylosing spondylitis. J Rheumatol 17:1482-1496, 1990
21. Mielants H, Veys EM: The gut in the spondyloarthropathies. J Rheumatol 17:7-10, 1990